Dr. Reddy's Laboratories Ltd.

₹6,611.65

up-down-arrow-48.25 (-0.72%)

As on 15-Oct-2024IST

Value Research Rating

4 star

Quality Score fund-quick-summary-circle

Quality Score9/10

Growth Score fund-quick-summary-circle

Growth Score6/10

Valuation Score fund-quick-summary-circle

Valuation Score5/10

Momentum Score fund-quick-summary-circle

Momentum Score2/10

Dr. Reddy's Laboratories Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 6,605.20 High: 6,699.90
52 Week Range
Low: 5,205.55 High: 7,107.45
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market cap

    ₹1,10,437 Cr

  • P/E Ratio

    19.84

  • P/B Ratio

    3.74

  • Industry P/E

    46.59

  • Debt to Equity

    0.01

  • ROE

    20.71 %

  • ROCE

    --

  • Div. Yield

    0.6 %

  • Book Value

    1768.37

  • EPS

    334

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Dr. Reddy'S Labs
14.04 -0.74 -1.60 21.09 10.06 20.05 8.46
BSE Sensex
13.26 -1.29 1.62 23.44 10.10 16.45 12.00
BSE Healthcare
41.84 0.99 16.54 58.12 19.17 29.56 12.67
As on 15-Oct-2024
2023
2022
2021
2020
2019
2018
2017
Dr. Reddy'S Labs
36.82 -13.64 -6.38 80.77 10.26 8.83 -21.11
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
loading...

Growth & Efficiency

Stock
Peer Median
loading...

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Peer Comparison Comparison Details

search
search
search
search
    loading...

    Shareholding Pattern Detailed Holdings

    News & Analysis All News

    Other details More Details

    Incorporated

    1984

    Chairman

    K Satish Reddy

    Managing Director

    GV Prasad

    Group

    Dr. Reddy's

    Headquarters

    Hyderabad, Telangana
    Edit peer-selector-edit
    loading...
    loading...
    loading...
    loading...

    Key Facts

    • Market cap market-cap-information ₹1,10,437.49 Cr
    • Revenue (TTM)revenue-information ₹28,949.30 Cr
    • Earnings (TTM) earning-information ₹5,565.30 Cr
    • Cash date-information ₹6,132.70 Cr
    • Total Debt info ₹2,002.00 Cr
    • Promoters' ownership promoters_ownership 26.65%
    • Liquidity liquidity High
    • 52 Week range week-range ₹5,205.55 - 7,107.45
    • Face value face-value ₹5.00
    • Shares outstanding share-outstanding 16,68,76,946
    • 10 Years Aggregate:

      CFO: ₹32,399.90 Cr

      EBITDA: ₹39,470.30 Cr

      Net Profit: ₹24,809.00 Cr

    About The Company

    • Incorporated 1984
    • Chairman K Satish Reddy
    • Managing Director GV Prasad
    • Group Dr. Reddy's
    • Listing key-listing BSE: 500124, NSE: DRREDDY
    • Country India
    • Headquarters headquarters Hyderabad, Telangana
    • Website website www.drreddys.com
    • Business

      Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The...  company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.  Read more

    FAQs for Dr. Reddy's Laboratories Ltd.

    The total asset value of Dr Reddy's Laboratories Ltd stood at ₹ 38,864 Cr as on 30-Jun-24

    The share price of Dr Reddy's Laboratories Ltd is ₹6,611.65 (NSE) and ₹6,617.90 (BSE) as of 15-Oct-2024 IST. Dr Reddy's Laboratories Ltd has given a return of 10.06% in the last 3 years.

    Dr Reddy's Laboratories Ltd has a market capitalisation of ₹ 1,10,437 Cr as on 15-Oct-2024. As per Value Research classification, it is a Large Cap company.

    The P/B ratio of Dr Reddy's Laboratories Ltd is 3.74 times as on 15-Oct-2024, a 45% discount to its peers’ median range of 6.85 times.

    The P/E ratio of Dr Reddy's Laboratories Ltd is 19.84 times as on 15-Oct-2024, a 57% discount to its peers’ median range of 46.59 times.

    Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
    Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
    Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
    Step 4. Search for the Dr Reddy's Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Dr Reddy's Laboratories Ltd.

    Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

    The prominent promoters of Dr. Reddy's Laboratories Ltd. are

    Name of promoters Holding percentage

    G V PRASAD

    11.52%

    SATISH REDDY KALLAM

    9.61%

    KALLAM SATISH REDDY HUF

    3.31%
    Click here to see the full list

    The chairman of the company is K Satish Reddy, and the managing director is GV Prasad.

    There is no promoter pledging in Dr Reddy's Laboratories Ltd.

    Some of the close peers are:

    Company Market Cap(₹ Cr)
    4,56,342
    1,28,832
    1,18,378
    1,11,956
    Dr. Reddy's Laboratories Ltd. Ratios
    Return on equity(%)
    20.71
    Operating margin(%)
    22.44
    Net Margin(%)
    18.58
    Dividend yield(%)
    0.6

    Yes, TTM profit after tax of Dr Reddy's Laboratories Ltd was ₹5,565 Cr.